Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer
Sponsors and Collaborators
Memorial Sloan-Kettering Cancer Center
Dean Bajorin, MD
Jonathan Rosenberg, MD
Dean Bajorin, MD, Memorial Sloan-Kettering Cancer Center
Next post in Bladder Cancer Clinical Trials
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
Want to read more?
Please login or register first to view this content.